Jade Biosciences Inc (JBIO)
Jade Biosciences stock today
Jade Biosciences closed at $14.06 on October 30, 2026, down 1.26% on the day. Over the past year it returned +42.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $694 million.
| Period | JBIO | S&P 500 (SPY) |
|---|---|---|
| 1 month | +0.1% | -0.9% |
| 3 months | -29.7% | +2.1% |
| Year to date | -8.9% | +11.7% |
| 1 year | +42.7% | +12.4% |
| 3 years | -95.0% | +88.5% |
| 5 years | -96.9% | +76.0% |
Key statistics
- Market value
- $694M
- 52-week range
- $8.95 to $26.85
- Next report
- Nov 12, 2026 (estimated)
About Jade Biosciences
Develops biopharmaceutical therapies, primarily focused on specialty therapeutics and drug development.
Sector: Health Care
More on Jade Biosciences
- Returns: what $1,000 became$1,000 five years ago is $31.19 today
No forecast, no recommendation. This page describes Jade Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.